American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. Washington, DC: American Psychiatric Association; 2000.
2.
BoysenGA: The scientific status of childhood dissociative identity disorder: A review of published research. Psychother Psychosom, 80:329–334, 2011.
3.
BrandBL, LaniusR, VermettenE, LoewensteinRJ, SpiegelD: Where are we going? An update on assessment treatment and neurobiological research in dissociative disorders as we move toward DSM-5. J Trauma Dissociation, 13:9–31, 2012.
4.
GentileJP, DillonKS, GilligPM: Psychotherapy and pharmacotherapy for patients with dissociative identity disorder. Innov Clin Neurosci, 10:22–29, 2013.
5.
HamnerM, DeitschS, BrodrickP, UlmerH, LorberbaumJ: Quetiapine treatment in patients with posttraumatic stress disorder: An open trial of adjunctive therapy. J Clin Psychopharmacol, 23:15–20, 2013.
6.
LaiCH. Dissociative identity disorder may be relieved by the combined treatments of mirtazapine and risperidone: Case report of an adolescent. J Neuropsychiatry Clin Neurosci, 24:E34, 2012.
7.
SnoHN, SchalkenHF: Dissociative identity disorder: Diagnosis and treatment in the Netherlands. Eur Psychiatry, 14:270–277, 1999.
8.
SokolskiKN, DensonTF, LeeRT, ReistC: Quetiapine for treatment of refractory symptoms of combat-related post-traumatic stress disorder. Mil Med, 168:486–489, 2003.
